Feb 4 • 13:17 UTC 🇩🇪 Germany Die Welt

"The market is relatively saturated - we see no big growth prospects anymore"

Danish pharmaceutical company Novo Nordisk has shocked investors with an unexpectedly gloomy outlook for 2026, causing its stock to plummet, as explained by market expert Andreas Lipkow in an interview.

📡 Similar Coverage